v3.19.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2019
Dec. 31, 2018
CURRENT ASSETS    
Cash & cash equivalents $ 135,288 $ 91,643
Accounts receivable 67,930 25,400
Inventory 0 6,499
Prepaid expenses 175,250 7,608
Total current assets 378,468 131,150
OTHER ASSETS    
Deferred offering costs 64,236 64,236
Pre-Production costs 111,000 0
Total other assets 175,236 64,236
Total Assets 553,704 195,386
CURRENT LIABILITIES    
Accounts payable - related parties 218,866 255,250
Accounts payable 111,725 16,142
Deferred revenue 45,358 0
Accrued interest, convertible notes payable 54,387 28,964
Convertible notes payable (net of unamortized debt discounts of $196,188 and $124,563 and unamortized debt premium of $2,106,386 and $504,386 respectively) 4,351,498 1,355,823
Total current liabilities 4,781,834 1,656,179
Total Liabilities 4,781,834 1,656,179
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, par value $.01 per share; 10,000,000 shares authorized, 240,000 issued and outstanding 2,400 2,400
Common stock, par value $.0001 per share; shares 2,000,000,000 authorized; 17,393,374 and 16,712,819 issued and outstanding as of June 30, 2019 and December 31, 2018 respectively 1,739 1,671
Additional paid-in capital (854,260) 567,738
Accumulated (deficit) (3,378,009) (2,032,602)
Total stockholders' equity (deficit) (4,228,130) (1,460,793)
Total Liabilities and Stockholder's Equity (Deficit) $ 553,704 $ 195,386